STAAR Surgical Past Earnings Performance
Past criteria checks 2/6
STAAR Surgical has been growing earnings at an average annual rate of 15.6%, while the Medical Equipment industry saw earnings declining at 2.5% annually. Revenues have been growing at an average rate of 18.9% per year. STAAR Surgical's return on equity is 5.1%, and it has net margins of 6.4%.
Key information
15.6%
Earnings growth rate
14.2%
EPS growth rate
| Medical Equipment Industry Growth | 4.3% |
| Revenue growth rate | 18.9% |
| Return on equity | 5.1% |
| Net Margin | 6.4% |
| Next Earnings Update | 19 Feb 2025 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How STAAR Surgical makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 27 Sep 24 | 341 | 22 | 189 | 53 |
| 28 Jun 24 | 333 | 17 | 186 | 50 |
| 29 Mar 24 | 326 | 15 | 184 | 47 |
| 29 Dec 23 | 322 | 21 | 179 | 44 |
| 29 Sep 23 | 310 | 20 | 179 | 43 |
| 30 Jun 23 | 306 | 26 | 171 | 41 |
| 31 Mar 23 | 295 | 33 | 158 | 38 |
| 30 Dec 22 | 284 | 40 | 143 | 36 |
| 30 Sep 22 | 279 | 38 | 133 | 35 |
| 01 Jul 22 | 262 | 34 | 125 | 34 |
| 01 Apr 22 | 243 | 29 | 117 | 34 |
| 31 Dec 21 | 230 | 28 | 112 | 34 |
| 01 Oct 21 | 217 | 23 | 104 | 34 |
| 02 Jul 21 | 206 | 21 | 96 | 34 |
| 02 Apr 21 | 179 | 11 | 84 | 33 |
| 01 Jan 21 | 163 | 6 | 80 | 32 |
| 02 Oct 20 | 156 | 9 | 78 | 30 |
| 03 Jul 20 | 148 | 7 | 76 | 28 |
| 03 Apr 20 | 153 | 13 | 77 | 27 |
| 03 Jan 20 | 150 | 14 | 75 | 25 |
| 27 Sep 19 | 142 | 9 | 72 | 24 |
| 28 Jun 19 | 135 | 8 | 69 | 23 |
| 29 Mar 19 | 129 | 6 | 67 | 22 |
| 28 Dec 18 | 124 | 5 | 63 | 22 |
| 28 Sep 18 | 118 | 4 | 60 | 22 |
| 29 Jun 18 | 109 | 3 | 54 | 21 |
| 30 Mar 18 | 97 | 1 | 49 | 21 |
| 29 Dec 17 | 91 | -2 | 48 | 20 |
| 29 Sep 17 | 88 | -2 | 45 | 19 |
| 30 Jun 17 | 84 | -5 | 46 | 19 |
| 31 Mar 17 | 84 | -6 | 46 | 18 |
| 30 Dec 16 | 82 | -12 | 50 | 21 |
| 30 Sep 16 | 81 | -13 | 51 | 20 |
| 01 Jul 16 | 80 | -13 | 50 | 19 |
| 01 Apr 16 | 78 | -12 | 49 | 18 |
| 01 Jan 16 | 77 | -7 | 43 | 15 |
| 02 Oct 15 | 73 | -8 | 42 | 14 |
| 03 Jul 15 | 72 | -9 | 42 | 13 |
| 03 Apr 15 | 74 | -9 | 43 | 12 |
| 02 Jan 15 | 75 | -8 | 44 | 12 |
| 03 Oct 14 | 77 | -7 | 46 | 11 |
| 04 Jul 14 | 76 | -3 | 46 | 10 |
| 04 Apr 14 | 74 | -1 | 43 | 9 |
Quality Earnings: SR3 has high quality earnings.
Growing Profit Margin: SR3's current net profit margins (6.4%) are lower than last year (6.6%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SR3's earnings have grown by 15.6% per year over the past 5 years.
Accelerating Growth: SR3's earnings growth over the past year (6.4%) is below its 5-year average (15.6% per year).
Earnings vs Industry: SR3 earnings growth over the past year (6.4%) did not outperform the Medical Equipment industry 10.1%.
Return on Equity
High ROE: SR3's Return on Equity (5.1%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/20 14:22 |
| End of Day Share Price | 2025/01/17 00:00 |
| Earnings | 2024/09/27 |
| Annual Earnings | 2023/12/29 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
STAAR Surgical Company is covered by 24 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Joanne Wuensch | BMO Capital Markets U.S. (Historical) |
| Michael Gorman | BTIG |
| John Young | Canaccord Genuity |